BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25144513)

  • 21. Plasma exchange in patients with ANCA-associated vasculitis.
    Chalkia A; Petras D
    Transfus Apher Sci; 2024 Feb; 63(1):103847. PubMed ID: 38008685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
    Jabur WL; Saeed HM
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary renal vasculitis syndromes.
    Lee RW; D'Cruz DP
    Autoimmun Rev; 2010 Aug; 9(10):657-60. PubMed ID: 20472100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pauci-immune necrotizing glomerulonephritis.
    Rutgers A; Sanders JS; Stegeman CA; Kallenberg CG
    Rheum Dis Clin North Am; 2010 Aug; 36(3):559-72. PubMed ID: 20688250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease.
    Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I
    Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-existing proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis with immunoglobulin A nephropathy.
    Kucuk A; Solak Y; Gaipov A; Bagcaci S; Esen H; Turk S; Tunc R
    Korean J Intern Med; 2016 Jan; 31(1):194-6. PubMed ID: 26767877
    [No Abstract]   [Full Text] [Related]  

  • 27. The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage.
    Goto K; Nakai K; Fujii H; Nishi S
    Intern Med; 2017; 56(1):55-59. PubMed ID: 28050000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Elderly Patients with Rapidly Progressive Glomerulonephritis.
    Hruskova Z; Tesar V
    Blood Purif; 2018; 45(1-3):213-217. PubMed ID: 29478046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results.
    Mahr A; Chaigne-Delalande S; De Menthon M
    Curr Opin Rheumatol; 2012 May; 24(3):261-6. PubMed ID: 22456283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.
    Noone D; Hebert D; Licht C
    Pediatr Nephrol; 2018 Jan; 33(1):1-11. PubMed ID: 27596099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ANCA associated vasculitis].
    Ryba M; Hruby Z; Witkiewicz W
    Przegl Lek; 2013; 70(3):149-56. PubMed ID: 24003670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An unusual presentation of C-ANCA vasculitis.
    Gavrilovski M; Kakar P; Rendle J; Lawrence E; Kee K; Sathanathan R
    QJM; 2012 Nov; 105(11):1105-7. PubMed ID: 21920993
    [No Abstract]   [Full Text] [Related]  

  • 33. Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy.
    Lorenzen J; Lovric S; Krämer R; Haller H; Haubitz M
    Ann Rheum Dis; 2010 Jun; 69(6):1169-71. PubMed ID: 20424002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ANCA associated vasculitis.
    Hunter RW; Welsh N; Farrah TE; Gallacher PJ; Dhaun N
    BMJ; 2020 Apr; 369():m1070. PubMed ID: 32291255
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of therapeutic plasmapheresis in ANCA-associated vasculitis.
    Walters G
    Pediatr Nephrol; 2016 Feb; 31(2):217-25. PubMed ID: 25986911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L1. Pathogenesis of ANCA-associated vasculitis: observations, theories and speculations.
    Charles Jennette J; Falk RJ
    Presse Med; 2013 Apr; 42(4 Pt 2):493-8. PubMed ID: 23465301
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis.
    Apaydin S
    Transfus Apher Sci; 2018 Feb; 57(1):8-12. PubMed ID: 29503131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome measures in ANCA-associated vasculitis.
    Suppiah R; Robson J; Luqmani R
    Rheum Dis Clin North Am; 2010 Aug; 36(3):587-607. PubMed ID: 20688252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Gaskin G; Pusey CD
    Ther Apher; 2001 Jun; 5(3):176-81. PubMed ID: 11467753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2008 Jan; 20(1):55-60. PubMed ID: 18281858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.